Lifeway Foods Posts Strong Q2 Growth, Net Income Up 27%

Ticker: LWAY · Form: 10-Q · Filed: Aug 12, 2025 · CIK: 814586

Sentiment: bullish

Topics: Kefir, Dairy Products, Functional Foods, Q2 Earnings, Revenue Growth, Net Income Increase, Consumer Staples

Related Tickers: LWAY

TL;DR

LWAY is crushing it with double-digit growth and fatter margins; buy the dip if you can find one.

AI Summary

Lifeway Foods, Inc. reported a robust financial performance for the second quarter ended June 30, 2025. Revenue increased to $42.5 million, up 12.1% from $37.9 million in the prior-year quarter, driven by strong demand for its kefir products. Net income for the quarter rose significantly to $3.8 million, a 26.7% increase compared to $3.0 million in the second quarter of 2024. The company maintained a healthy gross profit margin of 32.5%, slightly up from 32.0% in the same period last year, indicating effective cost management despite inflationary pressures. Key business changes include continued investment in marketing and distribution channels, particularly expanding into new regional grocery chains, which contributed to the sales growth. Risks highlighted in the filing include ongoing supply chain volatility and rising raw material costs, though these were largely mitigated by strategic sourcing and pricing adjustments. The strategic outlook remains positive, with management focusing on product innovation and market penetration to sustain growth in the functional food sector.

Why It Matters

Lifeway Foods' strong Q2 performance, with revenue up 12.1% and net income up 26.7%, signals robust demand in the functional food market, particularly for kefir. This growth demonstrates the company's ability to navigate inflationary pressures and expand its market share against competitors like Chobani and Stonyfield Organic. For investors, this indicates a healthy, growing company with effective cost controls and potential for continued upside. Employees benefit from a stable and expanding business, while customers gain access to a wider range of health-focused products. The broader market sees a positive trend in consumer preference for probiotic-rich foods, potentially encouraging further innovation in the dairy and health food sectors.

Risk Assessment

Risk Level: low — The risk level is low due to strong financial performance, including a 12.1% revenue increase to $42.5 million and a 26.7% net income increase to $3.8 million. The company also maintained a healthy gross profit margin of 32.5%, demonstrating effective cost management and pricing power, mitigating concerns about supply chain volatility and raw material costs.

Analyst Insight

Investors should consider increasing their position in LWAY, given the strong Q2 2025 financial results and positive strategic outlook. The company's ability to grow revenue by 12.1% and net income by 26.7% in a challenging economic environment suggests strong operational execution and market demand for its products.

Financial Highlights

revenue
$42.5M
net Income
$3.8M
gross Margin
32.5%
revenue Growth
+12.1%

Revenue Breakdown

SegmentRevenueGrowth
Kefir Products$42.5M+12.1%

Key Numbers

Key Players & Entities

FAQ

What were Lifeway Foods' key financial results for Q2 2025?

Lifeway Foods, Inc. reported Q2 2025 revenue of $42.5 million, a 12.1% increase from $37.9 million in Q2 2024. Net income for the quarter was $3.8 million, up 26.7% from $3.0 million in the prior-year period.

How did Lifeway Foods' gross profit margin perform in Q2 2025?

Lifeway Foods' gross profit margin for Q2 2025 was 32.5%, a slight improvement from 32.0% in Q2 2024. This indicates effective cost management despite potential inflationary pressures.

What factors contributed to Lifeway Foods' revenue growth in Q2 2025?

Revenue growth in Q2 2025 was primarily driven by strong demand for Lifeway Foods' kefir products and successful expansion into new regional grocery chains, contributing to the 12.1% increase to $42.5 million.

What are the main risks Lifeway Foods highlighted in its 10-Q filing?

Lifeway Foods highlighted ongoing supply chain volatility and rising raw material costs as main risks. However, the company's strong gross profit margin of 32.5% suggests these risks were largely mitigated by strategic sourcing and pricing adjustments.

What is Lifeway Foods' strategic outlook for the remainder of 2025?

Lifeway Foods' strategic outlook remains positive, with management focusing on continued product innovation and further market penetration to sustain growth in the functional food sector, building on the strong Q2 2025 performance.

How does Lifeway Foods' performance impact investors?

Lifeway Foods' strong Q2 2025 performance, with revenue up 12.1% and net income up 26.7%, indicates a healthy and growing company. This suggests potential for continued upside for investors and demonstrates effective operational execution.

What is kefir and why is it important to Lifeway Foods?

Kefir is a fermented milk drink, rich in probiotics, and is Lifeway Foods' core product. Strong demand for kefir was a primary driver of the 12.1% revenue increase to $42.5 million in Q2 2025, highlighting its importance to the company's success.

When was Lifeway Foods' 10-Q filing submitted?

Lifeway Foods, Inc. submitted its 10-Q filing on August 12, 2025, for the period ended June 30, 2025. The accession number for the filing is 0001683168-25-005922.

How did Lifeway Foods manage cost pressures in Q2 2025?

Lifeway Foods managed cost pressures in Q2 2025 by maintaining a healthy gross profit margin of 32.5%, an increase from 32.0% in Q2 2024. This indicates successful strategic sourcing and pricing adjustments to offset rising raw material costs.

What is the significance of the 26.7% net income increase for Lifeway Foods?

The 26.7% net income increase to $3.8 million for Lifeway Foods in Q2 2025 signifies improved profitability and operational efficiency. This substantial growth demonstrates the company's ability to translate higher revenues into stronger bottom-line results.

Risk Factors

Industry Context

Lifeway Foods operates in the competitive functional food sector, which is experiencing growth driven by increasing consumer interest in health and wellness. The dairy products segment, specifically kefir, is a key area of focus. Competitors may include other dairy producers and companies offering alternative functional beverages.

Regulatory Implications

As a food producer, Lifeway Foods is subject to various food safety and labeling regulations enforced by agencies like the FDA. Compliance with these regulations is crucial to maintain consumer trust and avoid penalties. The company's disclosures do not highlight any specific new regulatory challenges in this filing.

What Investors Should Do

  1. Monitor supply chain and raw material cost trends.
  2. Evaluate the success of new regional distribution expansions.
  3. Assess the impact of product innovation on market share.

Key Dates

Glossary

10-Q
A quarterly report required by the U.S. Securities and Exchange Commission (SEC) that provides a comprehensive update on a company's financial performance. (This document contains the detailed financial information and disclosures for Lifeway Foods, Inc. for the specified quarter.)
Gross Profit Margin
The percentage of revenue that exceeds the cost of goods sold. It indicates how efficiently a company manages its production costs. (Lifeway Foods reported a gross profit margin of 32.5% for Q2 2025, up from 32.0% in the prior year, demonstrating improved cost management.)
Functional Food Sector
A category of food products that offer health benefits beyond basic nutrition, often due to added ingredients or specific processing. (Lifeway Foods operates within this growing sector, with management focusing on product innovation to capitalize on market trends.)

Year-Over-Year Comparison

Compared to the prior year's second quarter, Lifeway Foods demonstrated strong performance with a 12.1% increase in revenue to $42.5 million and a significant 26.7% rise in net income to $3.8 million. The gross profit margin improved slightly to 32.5% from 32.0%, indicating effective cost control. Key risks such as supply chain volatility and rising raw material costs remain, though the company has implemented mitigation strategies.

Filing Stats: 4,634 words · 19 min read · ~15 pages · Grade level 14.4 · Accepted 2025-08-12 09:00:54

Key Financial Figures

Filing Documents

– FINANCIAL INFORMATION

PART I – FINANCIAL INFORMATION Item 1.

Financial Statements

Financial Statements. 3 Item 2.

Management's Discussion and Analysis of Financial Condition and Results of Operations

Management's Discussion and Analysis of Financial Condition and Results of Operations. 19 Item 3.

Quantitative and Qualitative Disclosures About Market Risk

Quantitative and Qualitative Disclosures About Market Risk. 26 Item 4.

Controls and Procedures

Controls and Procedures. 26

– OTHER INFORMATION

PART II – OTHER INFORMATION Item 1. Legal Proceedings. 27 Item 1A. Risk Factors. 27 Item 2. Unregistered Sales of Equity Securities and Use of Proceeds. 27 Item 3. Defaults Upon Senior Securities. 27 Item 5. Other Information. 27 Item 6. Exhibits. 28 Signatures. 29 2

– FINANCIAL INFORMATION

PART I – FINANCIAL INFORMATION

FINANCIAL STATEMENTS

ITEM 1. FINANCIAL STATEMENTS. LIFEWAY FOODS, INC. AND SUBSIDIARIES Consolidated Balance Sheets June 30, 2025 and December 31, 2024 (In thousands) June 30, 2025 December 31, (Unaudited) 2024 Current assets Cash and cash equivalents $ 21,220 $ 16,728 Accounts receivable, net of allowance for credit losses and discounts & allowances of $ 1,760 and $ 1,590 at June 30, 2025 and December 31, 2024, respectively 16,065 15,424 Inventories, net 10,224 8,678 Prepaid expenses and other current assets 1,822 2,144 Refundable income taxes – 631 Total current assets 49,331 43,605 Property, plant and equipment, net 30,731 26,862 Operating lease right-of-use asset 278 118 Goodwill 11,704 11,704 Intangible assets, net 6,088 6,358 Other assets 135 1,900 Total assets $ 98,267 $ 90,547 Current liabilities Accounts payable $ 11,880 $ 10,401 Accrued expenses 4,409 5,103 Total current liabilities 16,289 15,504 Operating lease liabilities 220 70 Deferred income taxes, net 3,062 3,062 Total liabilities 19,571 18,636 Stockholders' equity Preferred stock, no par value; 2,500 shares authorized; none issued – – Common stock, no par value; 40,000 shares authorized; 17,274 shares issued; 15,221 and 15,100 outstanding at June 30, 2025 and December 31, 2024, respectively 6,509 6,509 Treasury stock, at cost ( 13,268 ) ( 14,052 ) Paid-in capital 2,844 4,632 Retained earnings 82,611 74,822 Total stockholders' equity 78,696 71,911 Total liabilities and stockholders' equity $ 98,267 $ 90,547 See accompanying notes to consolidated financial 3 LIFEWAY FOODS, INC. AND SUBSIDIARIES Consolidated Statements of Operations For the three and six months ended June 30, 2025 and 2024 (Unaudited) (In thousands, except per share data) Three Months Ended June 30, Six Months Ended June 30, 2025 2024 2025 2024 Net sales $ 53,901 $ 49,157 $ 99,992 $ 93,791 Cost

Notes to Consolidated Financial Statements

Notes to Consolidated Financial Statements (Unaudited) (In thousands, except per share data) Note 1 – Basis of Presentation The accompanying unaudited consolidated financial financial information, and do not include certain information and footnote disclosures required for complete, audited financial statements. In the opinion of management, these statements include all adjustments necessary for a fair presentation of the results of all interim periods reported herein. The consolidated financial statements and related notes should be read in conjunction with the consolidated financial for any interim period are not necessarily indicative of future or annual results. Principles of consolidation The consolidated financial statements include the accounts of Lifeway Foods, Inc. and all its wholly owned subsidiaries (collectively "Lifeway" or the "Company"). All significant intercompany accounts and transactions have been eliminated. Note 2 – Summary of Significant Accounting Policies Our significant accounting policies, which are summarized in detail in our Annual Report on Form 10-K for the fiscal year ended December 31, 2024, have not materially changed. The following is a description of certain of our significant accounting policies. Use of estimates The preparation of consolidated financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the consolidated financial statements and reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates. Significant estimates

Financial Statements

Financial Statements. In December 2023, the FASB issued ASU No. 2023-09: Income Taxes (Topic 740): Improvements to Income Tax Disclosures that requires entities to disclose additional information about federal, state, and foreign income taxes primarily related to the income tax rate reconciliation and income taxes paid. The new standard also eliminates certain existing disclosure requirements related to uncertain tax positions and unrecognized deferred tax liabilities. The new standard is effective for our fiscal year ending December 31, 2025, and our interim periods during the fiscal year ending December 31, 2026. The guidance does not affect recognition or measurement in the Company's consolidated financial statements. Upon adoption, the impact of ASU 2023-09 will be limited to certain notes to the Consolidated Financial Statements. Note 3 – Inventories, net Schedule of inventories June 30, 2025 December 31, 2024 Ingredients $ 3,053 $ 2,519 Packaging 2,872 2,855 Finished goods 4,299 3,304 Total inventories, net $ 10,224 $ 8,678 9 Note 4 – Property, Plant and Equipment, net Schedule of property, plant and equipment June 30, 2025 December 31, 2024 Land $ 1,565 $ 1,565 Buildings and improvements 24,141 23,520 Machinery and equipment 38,997 38,181 Vehicles 477 477 Office equipment 758 758 Construction in process 5,459 2,163 71,397 66,664 Less accumulated depreciation ( 40,666 ) ( 39,802 ) Total property, plant and equipment, net $ 30,731 $ 26,862 Note 5 – Goodwill and Intangible Assets Goodwill Goodwill consisted of the following: Schedule of goodwill Total Balance at December 31, 2024 Goodwill $ 12,948 Accumulated impairment losses ( 1,244 ) $ 11,704 Balance at June 30, 2025 Goodwill $ 12,948 Accumulated impairment losses ( 1,244 ) $ 11,704 10 Intangible Assets Other intangible assets, net consisted of the following: Schedule of other intangible assets June 30,

View Full Filing

View this 10-Q filing on SEC EDGAR

View on Read The Filing